In Q4, Elevidys' revenue declined by about 2% year over year. Sarepta Therapeutics might have to deal with this issue for some time, and as long as it does, investors should stay away. The stock is ...

Tilray Brands has been struggling to grow its business of late. One stock that's at its all-time low right now is Tilray ...

Once a leading marijuana stock, the Canadian cannabis company has pivoted to craft beer and is trying to prevent being ...

Once considered a darling of the cannabis sector, shares of Tilray Brands TLRY have steadily declined over the past few years ...

Shares of Tilray Brands Inc. TLRY slid 3.28% to $0.43 Friday, on what proved to be an all-around mixed trading session for ...

One of the cannabis companies trying mightily to succeed is Tilray Brands (NASDAQ: TLRY), which shed more than 26% of its ...

Tilray has a proposed reverse stock split on the table that will help it avoid getting delisted from the Nasdaq. This move ...

Shares of Tilray Brands Inc. TLRY rallied 2.31% to $0.44 Thursday, on what proved to be an all-around positive trading ...

Will marijuana finally be reclassified as a less dangerous Schedule III substance by the DEA? Will Congress finally pass ...

Tilray Brands, parent company of SweetWater Brewing, recently moved up from sixth to fourth place in a ranking of craft breweries in the U.S.